Anxiety and depression in patients who undergo a cerebrovascular procedure

Lauren Lombardo1, Richard Shaw2, Kathleen Sayles2

  • 1The Valley Hospital, Ridgewood, NJ, USA. llombardo@neurosurgerynj.com.

BMC Neurology
|April 9, 2020
PubMed

Insights

Anxiety and depression negatively impact mental health outcomes 30 days after cerebrovascular procedures. However, these conditions did not affect long-term quality of life or other medical outcomes.

Area of Science:

  • Neurology
  • Psychiatry
  • Health Outcomes Research

Background:

  • Cerebrovascular procedures carry significant risks and potential impacts on patient well-being.
  • Understanding the influence of pre-existing mental health conditions like anxiety and depression is crucial for comprehensive patient care.

Purpose of the Study:

  • To investigate the relationship between pre-procedural anxiety and depression and quality of life outcomes following open and endovascular cerebrovascular procedures.
  • To identify potential demographic and clinical factors associated with anxiety and depression in this patient population.

Main Methods:

  • Retrospective analysis of 349 patients undergoing cerebrovascular procedures (aneurysm, AVM, hemorrhage, stenosis, stroke, angiogram).
  • Correlation of pre-procedural anxiety/depression with Global Physical Health, Global Mental Health, and Modified Rankin Scale scores.
  • Univariate and multivariate regression analyses adjusted for medical history and sociodemographics.

Main Results:

  • 18% of patients reported anxiety or depression, more common in females and younger individuals.
  • Patients with anxiety/depression had significantly lower mental health scores at 30 days post-procedure.
  • No significant differences were observed in length of stay, mortality, physical health, functionality, or 6-month quality of life outcomes.

Conclusions:

  • Pre-procedural anxiety and depression are associated with poorer mental health outcomes at 30 days post-cerebrovascular procedures.
  • These mental health conditions did not appear to influence longer-term medical or functional recovery at six months.
Abstract

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
309
Anxiety: Overview01:18

Anxiety: Overview

Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
783
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
673
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
563
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
931